Dragon Pharma Ipamorelin/Tesamorelin 10mg GH Blend Via

Ipamorelin/Tesamorelin 10 mg by Dragon Pharma is a dual-action growth hormone–modulating peptide blend combining the appetite-neutral GHRP Ipamorelin with the potent GHRH analog Tesamorelin. Together, they deliver a synergistic boost in growth hormone (GH) release, IGF-1 elevation, fat mobilization, anti-aging effects, and recovery enhancement. This combination offers a clean GH pulse from Ipamorelin and a deep, sustained GHRH effect from Tesamorelin, making it ideal for body recomposition, performance recovery, and longevity-focused research.

What It Is

This peptide blend combines two complementary GH-axis modulators:

• Ipamorelin – A selective GHRP with minimal cortisol or prolactin impact and no appetite spike.
• Tesamorelin – A synthetic GHRH analog known for its powerful ability to reduce visceral fat and significantly elevate IGF-1.

When combined, they stimulate the pituitary through both ghrelin (GHS-R) and GHRH receptors, producing high-quality GH pulses with extended duration. This makes the blend suitable for research on fat loss, regeneration, metabolic health, and anti-aging pathways. The peptide arrives as a 10 mg lyophilized vial, intended for reconstitution with bacteriostatic water.

How It Works

Ipamorelin activates the ghrelin receptor (GHS-R1a), triggering clean, controlled GH pulses with minimal side effects.

Tesamorelin stimulates GHRH receptors, promoting sustained GH and IGF-1 release while improving lipid metabolism and reducing visceral adiposity.

Combined, the blend produces a dual-pathway GH surge that enhances recovery, increases fat oxidation, improves sleep, boosts collagen production, and supports long-term anti-aging benefits. Tesamorelin uniquely targets visceral belly fat, making this blend especially effective in recomposition studies.

Ipamorelin/Tesamorelin Benefits

• Reduced Visceral Fat: Tesamorelin is clinically known for abdominal fat reduction.
• Powerful GH Release: Dual-receptor stimulation maximizes GH and IGF-1 output.
• Enhanced Recovery: Faster healing from training, stress, and micro-damage.
• Anti-Aging Effects: Improved sleep, skin elasticity, and cellular repair.
• Muscle Preservation: Helps maintain lean mass during caloric deficits.
• Appetite Neutral: Ipamorelin provides GH release without hunger spikes.

Who It's For

This dual peptide is used in research involving fat-loss studies, GH deficiency, anti-aging, metabolic improvement, body recomposition, and performance recovery. It is especially beneficial for protocols aiming to reduce stubborn abdominal fat while supporting lean muscle and recovery. Not recommended for individuals with active cancer or uncontrolled diabetes without strict supervision.

How to Use

Reconstitution: Add 1–2 ml bacteriostatic water to the 10 mg vial. Rotate gently to dissolve.

Administration: Inject subcutaneously into the abdomen or flank using an insulin syringe.

Timing: For optimal GH and fat-loss results, typical timing includes:

• Morning (fasted)
• Post-workout
• Before bedtime

Avoid carbohydrates and fats 30–45 minutes pre/post injection to prevent insulin-mediated GH suppression.

Cycle Duration: 6–12 weeks is common for body recomposition and anti-aging studies.

Stacking Suggestions

This blend pairs exceptionally well with other recovery and regeneration peptides:

• CJC-1295 no DAC / MOD-GRF 1-29: Further increases GH pulse amplitude.
• BPC 157 / TB-500: For enhanced healing and injury recovery.
• IGF-1 LR3: In advanced growth and repair studies.

Avoid stacking with peptides that heavily increase appetite (e.g., GHRP-6) unless the goal is mass gain.

Side Effects

Ipamorelin/Tesamorelin is well tolerated. Possible effects include:

• Mild Redness: At injection point.
• Temporary Water Retention: Due to GH fluctuations.
• Tingling or Warmth: After injection due to GH pulse.
• Altered Glucose Sensitivity: Tesamorelin may impact insulin response.

Side effects depend on dosage and individual sensitivity.

Post Cycle Therapy (PCT)

This blend does not suppress testosterone or affect androgen pathways, so PCT is not required. It can be used during or after PCT if stacked with suppressive compounds.